Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
about
Pharmacological and non-pharmacological interventions to influence adipose tissue function.Pharmacological effects of lipid-lowering drugs on circulating adipokines.Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.Dual Effect of Rosuvastatin on Glucose Homeostasis Through Improved Insulin Sensitivity and Reduced Insulin Secretion.Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy.Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemicsThe effect of simvastatin on glucose homeostasis in streptozotocin induced type 2 diabetic rats.Role of statins in coronary artery diseaseStatin use and the risk of cholecystectomy in womenVascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.Leptin and cardiovascular disease: response to therapeutic interventionsDifferential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?Alternative macrophage activation and metabolism.The good and bad effects of statins on insulin sensitivity and secretion.Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes.Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.
P2860
Q34576535-14DC27EF-46A7-4919-BE3F-283F5E5BD308Q34877922-D43CFD68-531F-4FBB-9A8E-603E54D13642Q35551787-BA81B3C3-BB90-47B7-8140-D0FB0B7D306EQ36084295-A20FAB3F-DB9F-495E-8B2E-61AE0008D644Q36187629-E2ED7993-8A0C-4196-94AA-2DD3AD09C7ADQ36788554-925D072D-4687-41C5-9DD7-F56916E54B8BQ36825795-0758DB6E-3D8D-46D3-8854-86422A0D1446Q36837567-CB29B432-2738-440A-98FB-A6E2FD2B6659Q36889150-662590D4-0D97-458C-AD26-19A7ED1364A2Q36894180-60908B27-058C-48A0-A60F-B9D81E9B5857Q37195539-2F03E19C-25BE-4625-B555-6BB714C32F8BQ37198354-23EC7C93-AAAA-43D1-9441-90CB579E5FE7Q37362218-501CB7F4-EF07-41A7-BA61-B7EDADF197F1Q37653189-8F0008A8-627B-4407-998D-D3C5BDDF4FDFQ37804862-4A590467-5FE1-429D-97D7-C83EB346CC15Q38248109-52724D19-0AFE-4BDE-AB14-D3A7D7810676Q38832643-07ACA869-0B22-485A-A813-9CFD2BC7387CQ46736149-6426BA84-A0B0-4798-9927-670A581164F2Q46921352-D2098C4B-83B6-4674-8EB4-79D21CFAC515
P2860
Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pravastatin does not affect in ...... healthy nondiabetic patients.
@en
Pravastatin does not affect in ...... healthy nondiabetic patients.
@nl
type
label
Pravastatin does not affect in ...... healthy nondiabetic patients.
@en
Pravastatin does not affect in ...... healthy nondiabetic patients.
@nl
prefLabel
Pravastatin does not affect in ...... healthy nondiabetic patients.
@en
Pravastatin does not affect in ...... healthy nondiabetic patients.
@nl
P2093
P1433
P1476
Pravastatin does not affect in ...... healthy nondiabetic patients.
@en
P2093
Georges Halaby
Mireille Amm-Azar
Myrna Germanos-Haddad
Rabih R Azar
Ramy Neemtallah
Simon Khalifé
P304
P356
10.1016/J.METABOL.2005.02.011
P577
2005-07-01T00:00:00Z